Hypothalamic gliosis tied to impaired glucose homeostasis in obesity and type 2 diabetes: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-01-24 04:30 GMT | Update On 2022-01-24 05:33 GMT

Seattle, WA: A recent study in the journal Diabetes Care has suggested a role of hypothalamic gliosis in insulin resistance progression in obesity and hence in the pathogenesis of type 2 diabetes (T2D) in humans.

Preclinical research had indicated hypothalamic glial cell responses to be involved in the pathogenesis of obesity and type 2 diabetes. In the study, Ellen A. Schur, UW Medicine Diabetes Institute, University of Washington, Seattle, WA, and colleagues aimed to translate such findings to humans by testing of radiologic markers of gliosis in the mediobasal hypothalamus (MBH) were higher in patients with obesity and impaired glucose homeostasis or T2D in a cross-sectional and prospective cohort study.

For this purpose, the researchers applied a validated quantitative MRI approach for assessing gliosis in 67 adults with obesity and normal glucose tolerance, impaired glucose tolerance (IGT), or T2D. Glucose homeostasis assessments were conducted via oral glucose tolerance tests (OGTT) and β-cell modeling.

The study revealed the following findings:

There was a significantly greater T2 relaxation times (a marker of gliosis by MRI), that were independent of adiposity, in the groups with IGT and T2D as compared with the group with normal glucose tolerance.
Findings were present in the MBH, but not control regions. Moreover, positive linear associations were present in the MBH but not control regions between T2 relaxation time and glucose area under the curve during an OGTT, fasting glucose concentrations, hemoglobin A_1c, and visceral adipose tissue mass, whereas negative linear relationships were present in the MBH for markers of insulin sensitivity and β-cell function.
In a prospective cohort study, greater MBH T2 relaxation times predicted declining insulin sensitivity over 1 year.

The authors conclude, our findings support a role for hypothalamic gliosis in the progression of insulin resistance in obesity and thus T2D pathogenesis in humans.

Reference:

Jennifer L. Rosenbaum, Susan J. Melhorn, Stefan Schoen, Mary F. Webb, Mary Rosalynn B. De Leon, Madelaine Humphreys, Kristina M. Utzschneider, Ellen A. Schur; Evidence That Hypothalamic Gliosis Is Related to Impaired Glucose Homeostasis in Adults With Obesity. Diabetes Care 2021; dc211535. https://doi.org/10.2337/dc21-1535

Article Source : Diabetes Care

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Hypothalamic gliosis tied to impaired glucose homeostasis in obesity and type 2 diabetes: Study

Similar News

BMI and Waist Circumference Show Mixed Links to Diabetic Complications in Type 2 Diabetes, Study Finds

Time-Restricted Eating Matches Calorie Restriction in Reducing Liver Fat in MASLD, Study Finds

More Microvascular Complications Raise Heart and Death Risk in Diabetes, reveals study

Lipid Accumulation Product strongest Predictor of Diabetes Among Visceral Obesity Indices: Study

Tirzepatide Tied to Lower Risk of Erectile Dysfunction in Men with Type 2 Diabetes: Study Reveals

Osteosarcopenia in Prediabetic Adults Linked to Nearly 3-Fold Higher Osteoarthritis Risk: NHANES Study

Medical Bulletin 05/Jul/2025

Investigational GLP-1 Receptor Agonist effective in Lowering HbA1c in Early Type 2 Diabetes: NEJM